Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 68,491 shares at $28.47 ($1.9M) on 2026-05-07, disclosed to the SEC on 2026-05-11.
Scheduled sale ($1.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.47 | 14,880 | $424K | 21.7% |
| 2 | $29.15 | 5,220 | $152K | 7.8% |
| 3 | $27.48 | 29,624 | $814K | 41.8% |
| 4 | $28.56 | 1,582 | $45K | 2.3% |
| 5 | $29.20 | 3,205 | $94K | 4.8% |
| 6 | $27.57 | 342 |
| $9K |
| 0.5% |
| 7 | $28.70 | 877 | $25K | 1.3% |
| 8 | $30.04 | 6,871 | $206K | 10.6% |
| 9 | $30.56 | 5,890 | $180K | 9.2% |
| Total | $28.47 avg | 68,491 | $1.9M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.4M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $521K | — | Filing → |